RESUMEN
OBJECTIVE@#Physical exercise, a common non-drug intervention, is an important strategy in cancer treatment, including hepatocellular carcinoma (HCC). However, the mechanism remains largely unknown. Due to the importance of hypoxia and cancer stemness in the development of HCC, the present study investigated whether the anti-HCC effect of physical exercise is related to its suppression on hypoxia and cancer stemness.@*METHODS@#A physical exercise intervention of swimming (30 min/d, 5 d/week, for 4 weeks) was administered to BALB/c nude mice bearing subcutaneous human HCC tumor. The anti-HCC effect of swimming was assessed in vivo by tumor weight monitoring, hematoxylin and eosin (HE) staining, and immunohistochemistry (IHC) detection of proliferating cell nuclear antigen (PCNA) and Ki67. The expression of stemness transcription factors, including Nanog homeobox (NANOG), octamer-binding transcription factor 4 (OCT-4), v-Myc avian myelocytomatosis viral oncogene homolog (C-MYC) and hypoxia-inducible factor-1α (HIF-1α), was detected using real-time reverse transcription polymerase chain reaction. A hypoxia probe was used to explore the intratumoral hypoxia status. Western blot was used to detect the expression of HIF-1α and proteins related to protein kinase B (Akt)/glycogen synthase kinase-3β (GSK-3β)/β-catenin signaling pathway. The IHC analysis of platelet endothelial cell adhesion molecule-1 (CD31), and the immunofluorescence co-location of CD31 and desmin were used to analyze tumor blood perfusion. SMMC-7721 cells were treated with nude mice serum. The inhibition effect on cancer stemness in vitro was detected using suspension sphere experiments and the expression of stemness transcription factors. The hypoxia status was inferred by measuring the protein and mRNA levels of HIF-1α. Further, the expression of proteins related to Akt/GSK-3β/β-catenin signaling pathway was detected.@*RESULTS@#Swimming significantly reduced the body weight and tumor weight in nude mice bearing HCC tumor. HE staining and IHC results showed a lower necrotic area ratio as well as fewer PCNA or Ki67 positive cells in mice receiving the swimming intervention. Swimming potently alleviated the intratumoral hypoxia, attenuated the cancer stemness, and inhibited the Akt/GSK-3β/β-catenin signaling pathway. Additionally, the desmin+/CD31+ ratio, rather than the number of CD31+ vessels, was significantly increased in swimming-treated mice. In vitro experiments showed that treating cells with the serum from the swimming intervention mice significantly reduced the formation of SMMC-7721 cell suspension sphere, as well as the mRNA expression level of stemness transcription factors. Consistent with the in vivo results, HIF-1α and Akt/GSK-3β/β-catenin signaling pathway were also inhibited in cells treated with serum from swimming group.@*CONCLUSION@#Swimming alleviated hypoxia and attenuated cancer stemness in HCC, through suppression of the Akt/GSK-3β/β-catenin signaling pathway. The alleviation of intratumoral hypoxia was related to the increase in blood perfusion in the tumor. Please cite this article as: Xiao CL, Zhong ZP, Lü C, Guo BJ, Chen JJ, Zhao T, Yin ZF, Li B. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway. J Integr Med. 2023; 21(2): 184-193.
Asunto(s)
Humanos , Animales , Ratones , Carcinoma Hepatocelular/tratamiento farmacológico , Proteínas Proto-Oncogénicas c-akt/metabolismo , Antígeno Nuclear de Célula en Proliferación/uso terapéutico , Ratones Desnudos , Glucógeno Sintasa Quinasa 3 beta/genética , beta Catenina/uso terapéutico , Neoplasias Hepáticas/tratamiento farmacológico , Desmina/uso terapéutico , Antígeno Ki-67 , Línea Celular Tumoral , Hipoxia , ARN Mensajero/uso terapéutico , Proliferación CelularRESUMEN
Polycystic ovary syndrome (PCOS) is a common disease caused by complex endocrine and metabolic abnormalities in women of childbearing age. Metformin is the most widely used oral hypoglycemic drug in clinic. In recent years, metformin has been used in the treatment of PCOS, but its mechanism is not clear. In this study, we aimed to investigate the effect of metformin on PCOS and its mechanism through PCOS mouse model. Female C57BL/6J mice aged 4-5 weeks were intragastrically given letrozole (1 mg/kg daily) combined with a high-fat diet (HFD) for 21 days to establish the PCOS model. After modeling, metformin (200 mg/kg daily) was intragastrically administered. One month later, the body weight and oral glucose tolerance test (OGTT) were measured. Hematoxylin eosin (H&E) staining was used to detect the pathological changes of ovary. The serum levels of anti-Mullerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), E2 and testosterone (T) were measured by ELISA. The expression of DDX4/MVH was detected by immunohistochemistry. DDX4/MVH and PCNA were co-labeled by immunofluorescence. The protein levels of DDX4/MVH, PCNA, cyclin D2, AMPK and mTOR were detected by Western blot. The results showed that after metformin treatment, the body weights of PCOS mice were gradually returned to normal, glucose tolerance was significantly improved, serum E2 levels were increased, while AMH, LH, T levels and LH/FSH ratio were decreased. Ovarian polycystic lesions were reduced with reduced atresia follicles. Furthermore, the number of proliferative female germline stem cells (FGSCs) and levels of proliferation related proteins (PCNA, cyclin D2) were significantly increased, and the p-mTOR and p-AMPK levels were markedly up-regulated. These results suggest that metformin treatment not only improves hyperandrogenemia, glucose intolerance and polycystic ovarian lesions in PCOS, but also activates the function of FGSCs. The underlying mechanism may be related to the phosphorylation of AMPK and mTOR. These findings provide new evidence to use metformin in the treatment of PCOS and follicular development disorder.
Asunto(s)
Animales , Femenino , Humanos , Ratones , Proteínas Quinasas Activadas por AMP , Ciclina D2 , Hormona Folículo Estimulante/uso terapéutico , Hormona Luteinizante/uso terapéutico , Metformina/farmacología , Ratones Endogámicos C57BL , Células Madre Oogoniales/metabolismo , Quistes Ováricos/tratamiento farmacológico , Neoplasias Ováricas , Síndrome del Ovario Poliquístico/tratamiento farmacológico , Antígeno Nuclear de Célula en Proliferación/uso terapéutico , Serina-Treonina Quinasas TORRESUMEN
Evaluación molecular de márgenes de resección en pacientes con carcinoma de células escamosas de cavidad oral sometidos a cirugía. 16 pacientes con carcinoma escamoso de cavidad oral, en cualquiera de sus localizaciones, sin tratamientos previos, intervenidos quirúrgicamente en el 2011. La pieza operatoria fue procesada por anatomía patológica a través del método tradicional, realizándose cortes adicionales que incluían: tumor y 0,5 cm de margen no tumoral. Se realizó hematoxilina-eosina y complementó con inmunomarcaje para p53, PCNA, Ki-67, factor de crecimiento epidérmico y receptor de crecimiento endotelial vascular. De los 16 pacientes en estudio la mayoría eran del género masculino, la edad promedio fue cercana a los 60 años, la mayoría eran pacientes consumidores de tabaco y alcohol. La lengua fue la localización más frecuente y los tumores se encontraban en un estadio avanzado (estadio III y IV). Estudio molecular: todos los marcadores evaluados se encontraban positivos en los márgenes de resección en el 93,75% de los pacientes. Los marcadores de proliferación celular como el PCNA y Ki-67 así como el p-53 se encontraban positivos entre 1,5 cm a 2 cm del tumor con un marcaje intenso. Por el contrario, el factor de crecimiento epidérmico el receptor de crecimiento endotelial vascular se encontraban positivos hasta 1,5 cm pero con menor intensidad. En el cáncer oral podemos observar con frecuencia cambios moleculares en el tejido aparentemente sano que rodea el tumor hasta por lo menos 15 mm.
The molecular evaluation of resection margins in patients with squamous cell carcinoma of oral cavity who underwent surgery. Field of cancerization concept. We included 16 patients with oral cavity squamous cell carcinoma in any of their locations,without pre treatment, surgically treated in our hospital in the 2011 year. The surgical specimen was processed by the pathology department of our institution, through the traditional method, additional sectioned including the tumor and at least 0.5 cm margin non tumorigenic. Study was performed hematoxylin eosin and was supplemented with immunostaining for p53, PCNA, Ki-67, epidermal growth factor receptor and vascular endothelial growth factor receptor. The most important features of the 16 patients studied were: The majorities were male, the average age was around 60 years old; most of them were tobacco and alcohol consumers. The tongue was the most frequent location and most of the tumors were in an advanced stage (stage III y IV). In molecular evaluation all the markers were positive in the resection margins in 93.75% of all patients. The cell proliferation markers suchas PCNA and Ki-67 and the p-53 were positive 1.5 cm to2 cm tumor with intense staining. Conversely, epidermal receptor grow factors and vascular endothelial grow factor receptor were positive up to 1.5 cm but with less intensity. In oral cancer can often observe molecular changes in the apparently healthy tissue surrounding the tumor to at least 15 mm.
Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , /uso terapéutico , Antígeno Nuclear de Célula en Proliferación/uso terapéutico , Boca/lesiones , Carcinoma de Células Escamosas/diagnóstico , Genes erbB-1 , Neoplasias de Cabeza y Cuello/diagnóstico , Receptor 1 de Factores de Crecimiento Endotelial Vascular/uso terapéutico , Odontología , Oncología MédicaRESUMEN
O carcinoma escamoso basalóide (CEB) tem sido considerado uma das variantes mais agressivas do carcinoma espinocelular (CEC), acometendo preferencialmente a base da língua, a hipofaringe e a laringe. Um total de 776 carcinomas espinocelulares primários de boca, cirurgicamente excisados entre 1970 e 2000, foram revisados dos arquivos dos Departamentos de Patologia e de Cirurgia de Cabeça e Pescoço e Otorrinolaringologia do Hospital do Câncer A.C. Camargo. Dezessete CEBs foram identificados e analisados comparativamente a 27 CECs pouco diferenciados com estadiamento e localizaçäo equivalentes, quanto ao gênero, idade, raça, tabagismo, etilismo, localizaçäo do tumor primário, classificaçäo pelo sistema TNM, tratamento, ocorrência de recidiva tumoral, metástases em linfonodos regionais, a distância e de segundo tumor primário. Analisaram-se a morfologia tumoral e a expressäo dos marcadores de proliferaçäo celular e apoptose: PCNA, p53, Bax e Bcl-X. As probabilidades de sobrevida, acumuladas nos períodos de 5 e 10 anos para ambos grupos tumorais, foram calculadas pelo método de Kaplan-Meier, sendo a influência das variáveis clínicas e microscópicas no prognóstico avaliada pelo modelo de regressäo de Cox. Morfologicamente, a maioria dos CEBs apresentou configuraçäo tumoral sólida/lobular, disposiçäo em paliçada das células periféricas, espaços císticos, comedonecrose, hialinizaçäo intra e peritumoral, disjunçäo epitélio tumoral/conjuntivo e associaçäo com o componente escamoso. Nenhuma diferença estatística foi detectada entre os grupos CEB e CEC quanto às características demográficas, clínicas e quanto à expressäo dos marcadores PCNA, p53 e Bcl-X. O CEB apresentou, comparativamente ao CEC, maior expressäo da proteína Bax (p=0,031). As probabilidades de sobrevida global, sobrevida específica e sobrevida livre de doença acumuladas em 5 e 10 anos para os pacientes com CEB e com CEC foram semelhantes. O estadiamento clínico N constituiu um fator prognóstico independente para os pacientes com carcinoma escamoso basalóide e carcinoma espinocelular pouco diferenciado na mucosa bucal. A morfologia tumoral, bem como a expressäo dos anticorpos PCNA, p53, Bax e Bcl-X, näo foram fatores prognósticos significativos. Estes resultados sugerem que, o CEB e o CEC pouco diferenciado com localizaçäo e estadiamento clínico equivalentes na boca, apresentam comportamento clínico e biológico similares...